Showing results (301-310 of 445) with videos related to
Sort By:
Pageof 45
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 9, 2005
Drug-eluting stents for coronary bifurcations: bench testing of provisional side-branch strategiesJohn A Ormiston, Mark W I Webster, Seifeddin El Jack, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 21, 2013
Renal denervation for resistant hypertension using an irrigated radiofrequency balloon: 12-month results from the Renal Hypertension Ablation System (RHAS) trialJohn A Ormiston, Timothy Watson, Niels van Pelt, et al.JACC. Cardiovascular Interventions|May 26, 2009
The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trialPatrick Gladding, Mark Webster, Irene Zeng, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 13, 2011
Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: insights from the ABSORB and SPIRIT trialsSalvatore Brugaletta, Josep Gomez-Lara, Roberto Diletti, et al.Coronary Artery Disease|December 13, 2012
Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesionsJohn A Ormiston, O'Shaughnessy Charles, Tift Mann, et al.Oncogene|December 22, 2022
Monitoring the 5'UTR landscape reveals isoform switches to drive translational efficiencies in cancerRamona Weber, Umesh Ghoshdastider, Daniel Spies, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 19, 2018
Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)Yuki Katagiri, Yoshinobu Onuma, Taku Asano, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 10, 2010
Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trialIan T Meredith, Stephen G Worthley, Robert Whitbourn, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 2017
Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patientsSoundarya N Selvam, Lara J Casey, Mackenzie L Bowman, et al.Journal of the American College of Cardiology|March 21, 2009
9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) studyStefan Verheye, Pierfrancesco Agostoni, Christophe L Dubois, et al.Pageof 45